Wednesday, November 27, 2024

Tirzepatide shows powerful diabetes-prevention effect in three-year trial

Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study.

from Top Health News -- ScienceDaily https://ift.tt/JtvU8qB
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Researchers map the brain's self-healing abilities after stroke

A new study sheds light on one of the most severe consequences of stroke: damage to the brain's 'cables'-- the so-called nerve f...